- Home
- CCSI vs KALV Comparison
CCSI vs KALV Comparison
Compare CCSI & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- KALV
- Stock Information
- Founded
- CCSI 2021
- KALV N/A
- Country
- CCSI United States
- KALV United States
- Employees
- CCSI N/A
- KALV N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- CCSI Technology
- KALV Health Care
- Exchange
- CCSI Nasdaq
- KALV Nasdaq
- Market Cap
- CCSI 475.1M
- KALV 563.1M
- IPO Year
- CCSI N/A
- KALV N/A
- Fundamental
- Price
- CCSI $23.51
- KALV $11.04
- Analyst Decision
- CCSI Hold
- KALV Strong Buy
- Analyst Count
- CCSI 5
- KALV 8
- Target Price
- CCSI $27.20
- KALV $24.83
- AVG Volume (30 Days)
- CCSI 155.8K
- KALV 552.8K
- Earning Date
- CCSI 05-07-2025
- KALV 03-12-2025
- Dividend Yield
- CCSI N/A
- KALV N/A
- EPS Growth
- CCSI 17.26
- KALV N/A
- EPS
- CCSI 4.62
- KALV N/A
- Revenue
- CCSI $350,382,000.00
- KALV N/A
- Revenue This Year
- CCSI $1.26
- KALV N/A
- Revenue Next Year
- CCSI $0.88
- KALV N/A
- P/E Ratio
- CCSI $4.96
- KALV N/A
- Revenue Growth
- CCSI N/A
- KALV N/A
- 52 Week Low
- CCSI $11.62
- KALV $7.30
- 52 Week High
- CCSI $32.10
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- CCSI 43.27
- KALV 42.52
- Support Level
- CCSI $22.47
- KALV $11.83
- Resistance Level
- CCSI $24.90
- KALV $11.78
- Average True Range (ATR)
- CCSI 0.86
- KALV 0.57
- MACD
- CCSI -0.01
- KALV -0.23
- Stochastic Oscillator
- CCSI 43.95
- KALV 8.42
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.